Bloomberg Businessweek Weekend - April 28th, 2023
Bloomberg Businessweek
00:00
The Risks and Benefits of Ozempic Wigovi
There are a number of less well-known drugs, including one called Muñjaro that hasn't been formally approved for obesity. There's also a drug called Wigovi, which was the first highly effective obesity drug approved in the US. All drugs are not without risks, including nausea, vomiting, and diarrhea,. And you actually have to titrate them up slowly. They're way more effective than anything that had been available for weight loss before. It's getting a lot of doctors and patients excited about it.
Play episode from 01:07:17
Transcript
